Figure S2 from TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy

crossref(2023)

引用 0|浏览5
暂无评分
摘要

Enzyme kinetic analysis of human dUTPase inhibition by TAS-114 and calculation of Km and Ki values

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要